ArticleFrontiers in systems biology2026
N-Gene and T-Gene deregulation networks: a data-driven causal framework for the analysis of gene interventions in cancer.
Article in Frontiers in systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mapping cancer dynamics from normal tissue to malignancy using N- and T-gene expression markers.Frontiers in systems biology · 2026Article
- Bidirectional network hubs: NT-genes as candidate targets for partial cancer reversal.Frontiers in systems biology · 2026Article
- N-Gene and T-Gene deregulation networks: a data-driven causal framework for the analysis of gene interventions in cancer.Frontiers in systems biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Current gene regulatory networks are limited by incomplete functional annotation and the difficulty of inferring causal relationships from expression data. Here we introduce Gene Deregulation Networks (GDNs), a new structure in which a directed link from gene C to gene E indicates that a deregulation of C makes a deregulation of E more probable. GDNs are inferred from expression data using a probabilistic theory of causation, without requiring prior biological knowledge. Methods: Using previously defined N- and T-genes with exclusive expression intervals for normal tissue and tumors, respectively, we construct separate GDNs for normal and for tumor tissues. Data are TCGA RNA-Seq Results: The GDNs are represented by sparse, directed acyclic graphs. Genes with low deregulation frequency have high out-degrees, suggesting they act as upstream regulators. High-frequency genes have high in-degrees, indicating they are convergence points of cascades. Projecting samples onto the T-GDN reveals that early tumors rely mostly on spontaneous T-gene activations, whereas advanced tumors show wide, branching cascades. The N-GDNs show consistent size and structure across distinct tissues revealing similar protective machinery against tumor formation. In contrast, the T-GDNs quantitatively differ from tissue to tissue indicating different levels of transcriptional reprogramming. Simulated knockdown of Conclusion: GDNs provide a robust, scalable, and annotation-free framework to understand cancer onset and progression. The separation into N- and T-GDNs, connected by NT-genes, offers a systematic basis for studying carcinogenesis and designing targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.